Tsingke Biotechnology Funding: $57M Raised, Series B (2022)
Tsingke Biotechnology is based in Beijing, China. It has raised $57M in total funding. Latest round: Series B.
Tsingke Biotechnology funding overview
Tsingke Biotechnology is based in Beijing, China. Tsingke Biotechnology has raised $57M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in December 2022. The round record for Tsingke Biotechnology runs through 2022; nothing later has been disclosed. Investors on record include Fortune Capital, Henan Investment Group Huirong Fund. 2 distinct backers are named across the disclosed rounds.
Tsingke Biotechnology at a glance
Total raised
$57M
Latest round
Series B
Latest round date
December 2022
Headquarters
Beijing, China
Notable investors
Fortune Capital, Henan Investment Group Huirong Fund
Frequently asked about Tsingke Biotechnology funding
How much has Tsingke Biotechnology raised?
Tsingke Biotechnology has raised $57M in total disclosed funding across the rounds on record.
Who has invested in Tsingke Biotechnology?
Fortune Capital, Henan Investment Group Huirong Fund are named among the investors backing Tsingke Biotechnology.
What was the latest Tsingke Biotechnology funding round?
The most recent disclosed round is a Series B, announced in December 2022.
Where is Tsingke Biotechnology based?
Tsingke Biotechnology is based in Beijing, China.
When did Tsingke Biotechnology last raise?
The last disclosed Tsingke Biotechnology round closed in December 2022 at Series B.
Round data for Tsingke Biotechnology is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Beijing and backer lists below.
